Nitric oxide and mitochondrial biogenesis in sepsis

脓毒症中的一氧化氮和线粒体生物发生

• 批准号: 8534342
• 负责人: CLAUDE A PIANTADOSI
• 金额: $ 31.4万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-08-23 至 2014-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8534342
• 关键词: 5' -AMP-activated protein kinase; Acute; Adenosine Monophosphate; Antibiotics; Apoptosis; Autophagocytosis; Biogenesis; Biological Models; Biology; CREB1 gene; Caring; Cell Death; Cell Nucleus; Cell Survival; Chemical Warfare; Chemicals; Complex; Critical Illness; Data; Development; Failure; Genes; Genetic; Goals; Gram-Positive Bacteria; Grant; Hepatic; Hepatocyte; Hypoxia; Infection; Inflammation; Inflammatory; Knowledge; Learning; Link; Liver; Mediating; Mediator of activation protein; Mitochondria; Mitochondrial DNA; Multiple Organ Failure; Mus; NF-kappa B; NOS2A gene; Nitric Oxide; Nitric Oxide Synthase; Nucleic Acids; Organ; Organ failure; Organelles; Oxidative Phosphorylation; Pathway interactions; Patients; Phenotype; Phosphorylation; Phosphotransferases; Physiological; Play; Prevalence; Prevention; Process; Production; Protein Kinase; Proteins; Quality Control; Receptor Activation; Regulation; Research; Role; Sentinel; Sepsis; Signal Transduction; Specificity; Standardization; Testing; Therapeutic; Titrations; Toll-like receptors; Transcriptional Regulation; Up-Regulation; Work; base; cost; design; enzyme activity; innovation; insight; mortality; novel; novel therapeutic intervention; nrf1 protein; prevent; pro-apoptotic protein; programs; repaired; respiratory; response; transcription factor

DESCRIPTION (provided by applicant): This revised competitive renewal application seeks to understand how nitric oxide (NO) production in bacterial sepsis causes both mitochondrial damage and regulates mitochondrial quality control, which protects against organ failure. In the previous grant cycle, we discovered that toll-like receptor (TLR) activation of NF-kB- dependent NO synthase (iNOS/NOS2) is involved in the regulation of hepatic mitochondrial biogenesis through the major co-activator, PGC-11 and the adenosine monophosphate (AMP)-activated protein kinase (AMPK). Our preliminary data in mice with sepsis indicate that: NOS2 induction leads to AMPK activation, AMPK helps to activate mitochondrial biogenesis, but not always after ATP depletion, and NOS2 deficiency diminishes AMPK up-regulation and mitochondrial biogenesis and increases apoptosis and inflammation in response to TLR activation. Thus, AMPK appears to activate mitochondrial biogenesis while opposing apoptosis and inflammation in sepsis. In contrast, too much NO is independently associated with mitochondrial damage and loss of NO signal specificity by chemical attack of NO species (NOx) on proteins and nucleic acids. We hypothesize that NOS2, acting in part through AMPK, is required for apposite regulation of the transcriptional program of mitochondrial biogenesis before the failure of ATP production in order to maintain mitochondrial quality control and prevent cell death in sepsis. A test of this hypothesis requires definitions of NO-dependent transcriptional control mechanisms, the role of AMPK, and the chemical biology of mitochondrial NO in relevant model systems. Our approach will focus on the liver as a sentinel organ and on one genetic factor- NOS2- as a quantitative influence on mitochondrial turnover and cell survival. We plan to test these Specific Aims: Aim 1: To determine the role of NOS2 on hepatic mitochondrial biogenesis and cell survival during severe sepsis through quantitative NOS2 gene titration studies. 1A. Define the relationships between NOx-mediated mtDNA and protein damage, respiratory capacity, high-energy metabolite levels, and sepsis-induced hepatic cell death using NOS2 titration. 1B. Assess the importance of NOS2 expression on the regulation of mitochondrial biogenesis in sepsis through CREB and/or NRF-1 induction and regulation of NRF-21 (GABPA) and/or PGC-11 expression. Aim 2: To understand hepatic AMPK activation in sepsis in relation to NOS2, the transcriptional program of mitochondrial biogenesis, and prevention of apoptosis. 2A. Determine if NO-dependent AMPK activation promotes mitochondrial biogenesis in sepsis through CREB and/or prevents apoptosis by inhibitory phosphorylation of pro-apoptotic proteins, Bad and BNIP3. 2B. Determine if pharmacological activation of AMPK in sepsis can promote mitochondrial biogenesis and/or inhibit apoptosis independently of NOS2. These studies will provide new insights into NOx-induced mitochondrial damage in sepsis in the context of physiological mechanisms by which NOS2 regulates mitochondrial biogenesis and the extent to which it is orchestrated by AMPK. By implication, NO regulation of AMPK would play a critical salvage role in MODS, and this knowledge would allow rational new pharmacological approaches to support mitochondrial function while minimizing collateral damage by NOx.

描述（由申请人提供）：此修订后的竞争性更新申请旨在了解细菌性脓毒症中一氧化氮（NO）的产生如何导致线粒体损伤并调节线粒体质量控制，从而防止器官衰竭。在之前的研究中，我们发现Toll样受体（TLR）激活NF-kB依赖的NO合酶（iNOS/NOS 2）通过主要的共激活因子PGC-11和腺苷酸（AMP）激活的蛋白激酶（AMPK）参与肝线粒体生物合成的调节。 我们在脓毒症小鼠中的初步数据表明：NOS 2诱导导致AMPK激活，AMPK有助于激活线粒体生物合成，但并不总是在ATP耗尽后，NOS 2缺乏减少AMPK上调和线粒体生物合成，并增加TLR激活引起的细胞凋亡和炎症。因此，AMPK似乎激活线粒体生物合成，同时对抗脓毒症中的细胞凋亡和炎症。相反，太多的NO与线粒体损伤和NO信号特异性的损失独立相关，NO物质（NOx）对蛋白质和核酸的化学攻击。我们推测，NOS 2，部分通过AMPK，需要适当的调节线粒体生物合成的转录程序之前，ATP生产失败，以保持线粒体质量控制和预防细胞死亡败血症。这一假设的测试需要定义NO依赖的转录控制机制，AMPK的作用，和线粒体NO在相关模型系统的化学生物学。我们的方法将集中在肝脏作为一个哨兵器官和一个遗传因子-NOS 2-作为线粒体周转和细胞存活的定量影响。我们计划测试这些特定的目的：目的1：通过定量NOS 2基因滴定研究确定NOS 2在严重脓毒症期间对肝线粒体生物合成和细胞存活的作用。1A.使用NOS 2滴定法确定NOx介导的mtDNA与蛋白质损伤、呼吸能力、高能代谢物水平和脓毒症诱导的肝细胞死亡之间的关系。1B.通过CREB和/或NRF-1诱导和NRF-21（GABPA）和/或PGC-11表达的调节，评估NOS 2表达对脓毒症中线粒体生物发生调节的重要性。目标二：了解脓毒症中肝脏AMPK激活与NOS 2、线粒体生物合成的转录程序和细胞凋亡的预防的关系。2A.确定NO依赖性AMPK激活是否通过CREB促进脓毒症中的线粒体生物合成和/或通过抑制促凋亡蛋白Bad和BNIP 3的磷酸化来防止凋亡。 2B.确定在脓毒症中AMPK的药理学激活是否可以独立于NOS 2促进线粒体生物合成和/或抑制细胞凋亡。 这些研究将为脓毒症中NOx诱导的线粒体损伤提供新的见解，即NOS 2调节线粒体生物合成的生理机制及其由AMPK协调的程度。通过暗示，NO调节AMPK将在MODS中发挥关键的挽救作用，并且这种知识将允许合理的新药理学方法来支持线粒体功能，同时最小化NOx的附带损伤。